Skip to content

Effectiveness of repetitive transcranial magnetic stimulation (rTMS) combined with cervical nerve root stimulation on upper limb motor function after stroke: A Randomized clinical Trial

Effectiveness of repetitive transcranial magnetic stimulation (rTMS) combined with cervical nerve root stimulation on upper limb motor function after stroke: A Randomized clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048558
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group:True stimulation of the affected side of the M1 area - true stimulation of the cervical nerve root
Control group1:True stimulation of ipsilateral M1 area - sham stimulation of cervical nerve root
Control group2:Ipsilateral M1 area sham stimulation - cervical nerve root stimulation
Control group3:Ipsilateral M1 area sham stimulation - cervical nerve root sham stimulation

Sponsors

Tangdu Hospital, Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The initial onset, in line with the diagnostic criteria for stroke, unilateral lesions, confirmed by CT or MRI as hemorrhagic or ischemic lesions in the basal ganglia region; 2. Course of disease 2 weeks to 6 months, male or female, aged 30 to 80 years; 3. Be conscious and have stable vital signs at the time of enrollment; 4. There is upper limb dysfunction and Brunnstrom stage I to III of the upper limb on the affected side; 5. Willingness to take active rehabilitation and can cooperate with treatment instructions; 6. The patient and (or) authorized family members of the patient understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment or mental illness; 2. There is a metal foreign body in the skull; 3. Those with a history of epilepsy or a family history of epilepsy; 4. Those with pacemakers, stents and cochlear implants; 5. Those who cannot tolerate treatment; 6. Those with severe liver and kidney disease; 7. Those who cannot cooperate with the follow-up.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer score;Wolf motor function test;

Secondary

MeasureTime frame
Brunnstrom evaluation of motor function in hemiplegia;Modified Barthel Index;

Countries

China

Contacts

Public ContactLiu Rui

Tangdu Hospital, Air Force Military Medical University

speciallr@163.com+86 15002995399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026